DDX41: exploring the roles of a versatile helicase

被引：2
|
作者：
Winstone, Lacey [1 ]
Jung, Yohan [1 ]
Wu, Yuliang [1 ]
机构：
[1] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
来源：
BIOCHEMICAL SOCIETY TRANSACTIONS | 2024年 / 52卷 / 01期
基金：
加拿大自然科学与工程研究理事会;
关键词：
ACUTE MYELOID-LEUKEMIA; I IFN PRODUCTION; CYCLIC-DI-AMP; FUNCTIONAL-CHARACTERIZATION; R-LOOP; FAMILY; MUTATIONS; VARIANTS; SENSOR; EXPRESSION;
D O I：
10.1042/BST20230725
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
DDX41 is a DEAD-box helicase and is conserved across species. Mutations in DDX41 have been associated with myeloid neoplasms, including myelodysplastic syndrome and acute myeloid leukemia. Though its pathogenesis is not completely known, DDX41 has been shown to have many cellular roles, including in pre-mRNA splicing, innate immune sensing, ribosome biogenesis, translational regulation, and R -loop metabolism. In this review, we will summarize the latest understandings regarding the various roles of DDX41, as well as highlight challenges associated with drug development to target DDX41. Overall, understanding the molecular and cellular mechanisms of DDX41 could help develop novel therapeutic options for DDX41 mutation-related hematologic malignancies.
引用
收藏
页码：395 / 405
页数：11
相关论文
共 50 条
  • [41] Structural and functional analyses of human DDX41 DEAD domain
    Jiang, Yan
    Zhu, Yanping
    Qiu, Weicheng
    Liu, Yong-Jun
    Cheng, Genhong
    Liu, Zhi-Jie
    Ouyang, Songying
    PROTEIN & CELL, 2017, 8 (01) : 72 - 76
  • [42] Characteristics and Outcomes of Patients With Myelodysplastic Syndrome and DDX41 Mutation
    Bataller, Alex
    Loghavi, Sanam
    Gerstein, Yoheved
    Bazinet, Alexandre
    Sasaki, Koji
    Chien, Kelly S.
    Hammond, Danielle
    Montalban-Bravo, Guillermo
    Borthakur, Gautam
    Short, Nicholas
    Issa, Ghayas C.
    Kadia, Tapan M.
    Daver, Naval
    Patel, Keyur P.
    Ravandi, Farhad
    Fiskus, Warren
    Mill, Cristopher P.
    Kantarjian, Hagop M.
    Bhalla, Kapil
    Garcia-Manero, Guillermo
    Oran, Betul
    DiNardo, Courtney D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S357 - S358
  • [43] Clinical and Pathologic Spectrum of DDX41 Mutated Hematolymphoid Neoplasms
    Goyal, Tanu
    Tu, Zheng Jin
    Cook, James
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1305 - 1306
  • [44] Disease Characteristics of AML Patients with Germline DDX41 Variants
    Vagher, Jennie
    Venkatachalam, Shobi
    Li, Peng
    Asch, Julie D.
    Huber, Bryan D.
    Tashi, Tsewang
    Shami, Paul J.
    Kovacsovics, Tibor
    Maese, Luke
    Parker, Charles J.
    Tantravahi, Srinivas K.
    BLOOD, 2021, 138
  • [45] Role of Ddx41 in the Stimulator of Interferon Genes (STING) Pathway
    Curran, Emily
    Mattingly, Jacob
    Godley, Lucy
    Kline, Justin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S395 - S395
  • [46] Novel DDX41 variants in Thai patients with myeloid neoplasms
    Chantana Polprasert
    June Takeda
    Pimjai Niparuck
    Thanawat Rattanathammethee
    Arunrat Pirunsarn
    Amornchai Suksusut
    Sirorat Kobbuaklee
    Kitsada Wudhikarn
    Panisinee Lawasut
    Sunisa Kongkiatkamon
    Suporn Chuncharunee
    Kritanan Songserm
    Prasit Phowthongkum
    Udomsak Bunworasate
    Yasuhito Nannya
    Kenichi Yoshida
    Hideki Makishima
    Seishi Ogawa
    Ponlapat Rojnuckarin
    International Journal of Hematology, 2020, 111 : 241 - 246
  • [47] GERMLINE DDX41 MUTATIONS : CLINICAL IMPACT & ETHNIC DIVERSITY
    Makishima, H.
    LEUKEMIA RESEARCH, 2023, 128
  • [48] BEYOND DDX41: DDH AND DHX HELICASES ARE MUTATED IN MDS
    Gurnari, C.
    Durmaz, A.
    Kubota, Y.
    Ogbue, O.
    Awada, H.
    Kawashima, N.
    Laframboise, T.
    Padgett, R.
    Haferlach, T.
    Maciejewski, J.
    Visconte, V.
    LEUKEMIA RESEARCH, 2023, 128
  • [49] Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms
    Makishima, Hideki
    Nannya, Yasuhito
    Takeda, June
    Momozawa, Yukihide
    Saiki, Ryunosuke
    Yoshizato, Tetsuichi
    Atsuta, Yoshiko
    Iijima-Yamashita, Yuka
    Yoshida, Kenichi
    Shiraishi, Yuichi
    Nagata, Yasunobu
    Shiozawa, Yusuke
    Onizuka, Makoto
    Chiba, Kenichi
    Tanaka, Hiroko
    Kakiuchi, Nobuyuki
    Ochi, Yotaro
    Ueno, Hiroo
    Itonaga, Hidehiro
    Kanda, Yoshinobu
    Sanada, Masashi
    Kon, Ayana
    Miyazaki, Yasushi
    Horibe, Keizo
    Tobiasson, Magnus
    Tsurumi, Hisashi
    Kasahara, Senji
    Polprasert, Chantana
    Lindberg, Eva Hellstrom
    Takaori, Akifumi Kondo
    Kiguchi, Toru
    Cazzola, Mario
    Matsuda, Fumihiko
    Ohyashiki, Kazuma
    Maciejewski, Jaroslaw P.
    Haferlach, Torsten
    Kamatani, Yoichiro
    Kubo, Michiaki
    Miyano, Satoru
    Ogawa, Seishi
    BLOOD, 2020, 136
  • [50] Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia
    Chlon, Timothy M.
    Stepanchick, Emily
    Hershberger, Courtney E.
    Daniels, Noah J.
    Hueneman, Kathleen M.
    Davis, Ashley Kuenzi
    Choi, Kwangmin
    Zheng, Yi
    Gurnari, Carmelo
    Haferlach, Torsten
    Padgett, Richard A.
    Maciejewski, Jaroslaw P.
    Starczynowski, Daniel T.
    CELL STEM CELL, 2021, 28 (11) : 1966 - +
12345